BIOS - Option Care Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.5900
+0.0600 (+1.70%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close3.5300
Open3.5000
Bid0.0000 x 4000
Ask0.0000 x 3100
Day's Range3.5000 - 3.6000
52 Week Range1.5600 - 4.1400
Volume531,416
Avg. Volume1,002,596
Market Cap2.534B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    Option Care Health Announces Third Quarter Results

    BANNOCKBURN, Ill., Nov. 06, 2019 -- Option Care Health, Inc. (Nasdaq: BIOS), the nation’s largest independent provider of home and alternate site infusion services, today.

  • GlobeNewswire

    Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call

    BANNOCKBURN, Ill., Oct. 16, 2019 -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services,.

  • GlobeNewswire

    Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCare

    The Providence Service Corporation (the “Company” or “Providence”) (PRSC) today announced that it has appointed Kathryn Stalmack to serve as Senior Vice President, General Counsel and Corporate Secretary of Providence and its subsidiary, LogistiCare Solutions, LLC (“LogistiCare”).  Ms. Stalmack will be responsible for all legal matters relevant to the Company including contracting, litigation, corporate governance and regulatory compliance.  Ms. Stalmack succeeds M. Chinta Gaston, who is retiring and previously served Senior Vice President, General Counsel and Secretary of Providence since January 2019 and served as LogistiCare’s General Counsel since 2003.

  • GlobeNewswire

    BioScrip Announces Shareholder Approval of Merger with Option Care

    BioScrip’s merger with Option Care is expected to close on or about August 6, 2019. BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting.

  • GlobeNewswire

    BioScrip Reports Second Quarter 2019 Financial Results

    DENVER, July 30, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire

    Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care

    BioScrip, Inc. (BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”), leading independent proxy advisory firms, recommend that BioScrip stockholders vote “FOR” the proposals that are conditions to the proposed merger with Option Care, at the special meeting of stockholders to be held on August 2, 2019. BioScrip’s Board of Directors encourages stockholders to vote “FOR” each of the proposals relating to the combination with Option Care.  The merger is expected to close in early August 2019 after the special meeting of stockholders.

  • GlobeNewswire

    BIOS, CRAY, ZAYO SHAREHOLDER LEGAL UPDATE: Halper Sadeh LLP Announces Shareholder Class Actions Against the Following Companies – BIOS, CRAY, ZAYO

    NEW YORK, June 26, 2019 -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of shareholder class action lawsuits against BioScrip, Inc. (NASDAQ: BIOS),.

  • GlobeNewswire

    LogistiCare Announces Leadership Transition

    The Providence Service Corporation (“Providence”) (PRSC) and its subsidiary, LogistiCare Solutions, LLC (“LogistiCare”), today announced that effective immediately R. Carter Pate will serve as Interim Chief Executive Officer of LogistiCare.  Mr. Pate will continue his duties as Providence’s Interim CEO and assumes the responsibilities of Jeff Felton, who has resigned as CEO of LogistiCare effective immediately. Mr. Pate will remain as Interim CEO of Providence and LogistiCare until December 31, 2019.  Over the next six months, Mr. Pate will work with Providence’s Board of Directors to conduct a search internally and externally to identify a permanent CEO for the combined business. Carter Pate is the Founder and Chief Executive Officer of Carter Pate, LLC, a consulting firm he founded in 2014.  Since 2017 he has served as the Interim CEO of Providence Service Corporation (PRSC).

  • PR Newswire

    URGENT ALERT: Monteverde & Associates PC Launches an Investigation Regarding the Following Merger

    NEW YORK , June 21, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

  • GlobeNewswire

    Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger

    Dan Greenleaf, President and Chief Executive Officer of BioScrip, will become Special Advisor to the newly combined company’s Board Chairman, Harry Kraemer, and Chief Executive Officer, John Rademacher.   Mr. Greenleaf will provide strategic and operational counsel to ensure a smooth transition, optimize the integration of both companies, and drive long-term growth opportunities.

  • GlobeNewswire

    RLH Corporation Announces Changes to Its Board of Directors

    Adds Accomplished Independent Director R. Carter Pate to Board and Audit Committee Announces Retirement of Director, James P. Evans, Chair of the Board’s Nominating and.

  • GlobeNewswire

    BioScrip to Participate in Upcoming Investor Conferences

    Given BioScrip’s pending combination with Option Care, Option Care’s Chief Executive Officer, John Rademacher, and Chief Financial Officer, Mike Shapiro, plan to accompany BioScrip’s senior leadership at these events.  A live webcast of the Jefferies group presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://investors.bioscrip.com/ or through the following link: http://wsw.com/webcast/jeff118/bios/.

  • GlobeNewswire

    MERGER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of BioScrip, Inc. – BIOS

    NEWTOWN SQUARE, Pa., May 03, 2019 -- Kaskela Law LLC announces that it is investigating BioScrip, Inc. (“BioScrip” or the “Company”) (Nasdaq: BIOS) on behalf of the Company’s.

  • GlobeNewswire

    BioScrip Reports First Quarter 2019 Financial Results

    DENVER, May 02, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire

    BioScrip, Inc. Provides Merger Update

    BioScrip, Inc. (BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with Option Care Enterprises, Inc. (“Option Care”). The Company expects to file the preliminary Option Care merger proxy statement the week of April 29, 2019 with the U.S. Securities and Exchange Commission (“SEC”).  After the proxy statement is filed, management from both BioScrip and Option Care plan to conduct joint analyst and investor meetings.  As part of the analyst and investor meetings, the Company will file an investor presentation with the SEC that will include a business and merger update.

  • ACCESSWIRE

    Merger Agreement and Earnings Review in this Comprehensive Report on BioScrip

    NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on BioScrip Inc. (BIOS), a provider of infusion and home care management solutions, with approximately 2,500 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. Recently, BioScrip and Option Care jointly announced a definitive merger agreement, which will create the nation's preeminent home infusion company and transform the industry. Option Care's signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support, and care coordination.

  • GlobeNewswire

    BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results

    DENVER, March 15, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire

    Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge

    DENVER and BANNOCKBURN, Ill., March 15, 2019 (GLOBE NEWSWIRE) --  BioScrip, Inc. (BIOS) (“BioScrip”) and Option Care Enterprises, Inc. (“Option Care”), the nation’s largest independent providers of home and alternate treatment site infusion therapy services, today announced that they have entered into a definitive merger agreement. The combination is expected to create a leading independent provider with the national reach, comprehensive therapy offering and financial capacity to succeed in the attractive and growing home and alternate site infusion services segment of the $100 billion U.S. infusion market.

  • ACCESSWIRE

    BioScrip, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 15, 2019 / BioScrip, Inc. (NASDAQ: BIOS ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 15, 2019, 2018 at 9:00 AM ...

  • GlobeNewswire

    BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

    DENVER, March 13, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire

    BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

    DENVER, Feb. 25, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire

    Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019

    NEW YORK, Jan. 22, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.